360 related articles for article (PubMed ID: 18564011)
1. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.
Jelinek T; Kollaritsch H
Expert Rev Vaccines; 2008 Jul; 7(5):561-7. PubMed ID: 18564011
[TBL] [Abstract][Full Text] [Related]
2. Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea.
Lundkvist J; Steffen R; Jönsson B
J Travel Med; 2009; 16(1):28-34. PubMed ID: 19192125
[TBL] [Abstract][Full Text] [Related]
3. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
Ahmed T; Bhuiyan TR; Zaman K; Sinclair D; Qadri F
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009029. PubMed ID: 23828581
[TBL] [Abstract][Full Text] [Related]
4. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
Zhang W; Sack DA
Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
[TBL] [Abstract][Full Text] [Related]
5. [Examples for vaccines against diarrheal diseases--rotavirus and traveller's diarrhea].
Kollaritsch H; Wiedermann U
Wien Med Wochenschr; 2007; 157(5-6):102-6. PubMed ID: 17427005
[TBL] [Abstract][Full Text] [Related]
6. Vaccines against traveler's diarrhoea and rotavirus disease - a review.
Wiedermann U; Kollaritsch H
Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):2-8. PubMed ID: 17131234
[TBL] [Abstract][Full Text] [Related]
7. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.
Svennerholm AM
Indian J Med Res; 2011 Feb; 133(2):188-96. PubMed ID: 21415493
[TBL] [Abstract][Full Text] [Related]
8. Prevention of fecal-orally transmitted diseases in travelers through an oral anticholeric vaccine (WC/rBS).
Gabutti G; Aquilina M; Cova M; Giuffrida S; Lizioli A; Protano D; Scrivano F; Tomasi A; Cucchi A; Cavallaro A;
J Prev Med Hyg; 2012 Dec; 53(4):199-203. PubMed ID: 23469588
[TBL] [Abstract][Full Text] [Related]
9. Vaccines against enterotoxigenic Escherichia coli.
Svennerholm AM; Tobias J
Expert Rev Vaccines; 2008 Aug; 7(6):795-804. PubMed ID: 18665777
[TBL] [Abstract][Full Text] [Related]
10. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.
López-Gigosos R; García-Fortea P; Reina-Doña E; Plaza-Martín E
Travel Med Infect Dis; 2007 Nov; 5(6):380-4. PubMed ID: 17983977
[TBL] [Abstract][Full Text] [Related]
12. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
[TBL] [Abstract][Full Text] [Related]
13. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
Tobias J; Svennerholm AM
Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
[TBL] [Abstract][Full Text] [Related]
14. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
15. Vaccines for enterotoxigenic Escherichia coli: current status.
Boedeker EC
Curr Opin Gastroenterol; 2005 Jan; 21(1):15-9. PubMed ID: 15687879
[TBL] [Abstract][Full Text] [Related]
16. Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs.
Takeyama N; Yuki Y; Tokuhara D; Oroku K; Mejima M; Kurokawa S; Kuroda M; Kodama T; Nagai S; Ueda S; Kiyono H
Vaccine; 2015 Sep; 33(39):5204-11. PubMed ID: 26254309
[TBL] [Abstract][Full Text] [Related]
17. [Advances in new vaccines against human enterotoxigenic Escherichia coli--A review].
Xia P; Meng X; Zhu G
Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):198-208. PubMed ID: 27373068
[TBL] [Abstract][Full Text] [Related]
18. Statement on new oral cholera and travellers' diarrhea vaccination.
;
Can Commun Dis Rep; 2005 Jul; 31(ACS-7):1-11. PubMed ID: 15999424
[No Abstract] [Full Text] [Related]
19. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report).
Wiedermann G; Kollaritsch H; Kundi M; Svennerholm AM; Bjare U
J Travel Med; 2000 Jan; 7(1):27-9. PubMed ID: 10689236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
